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81%, respectively) than in all other
groups (w2, Po0.05). As expected and
also shown in Figure 1c, IgG4 anti-
Dsg1 was detected in a large number
of FS, PF, and PV patients (90, 77, and
33% respectively), which is a known
feature of these diseases. These findings
suggest a persistent antigenic stimula-
tion of the immune system of indivi-
duals living in the endemic areas of FS.
In summary, our findings further
support the notion that the anti-Dsg1
response in FS patients may be initiated
by sensitization to an environmental
allergen(s). The crossreactive IgE, IgM,
and pathogenic IgG4 anti-Dsg1 res-
ponse may be the serological markers
of these immunological responses.
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TO THE EDITOR
The occurrence of allergies is rapidly
increasing in the Western world, with
allergic rhinoconjunctivitis to airborne
allergens being the most common con-
dition. The diagnosis of allergic rhino-
conjunctivitis is based on a history of
clinical symptoms, typically during the
pollen season, and skin testing with
the respective allergen. A positive skin
prick test (SPT) is taken as an indication
for IgE-mediated mast cell (MC) degra-
nulation. As it has recently been shown
that pollen release not only allergens
but also bioactive mediators that
can activate and modulate immune
cells (Traidl-Hoffmann et al., 2009), we
hypothesized that non-allergic pollen-
derived factors can induce inflamma-
tion both in patients and in non-allergic
mice. We, therefore, assessed the levels
of specific IgE against birch or ambrosia
in 184 consecutive patients seen at the
outpatient clinics of the Allergie-Cen-
trum-Charite´ in Berlin, Germany, with a
positive history for allergic symptoms to
birch (146 patients) or ambrosia (38
patients), and positive SPT to the res-
pective allergens. In accordance with
previously reported findings (Bodtger
et al., 2003), we found that 13% of our
patients with positive SPT to birch hadAbbreviations: APE, aqueous pollen extract; MC, mast cell; SPT, skin prick test
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very low serum levels of specific IgE
against birch (CAP class 0 or 1, i.e.,
specific IgE o0.7 kU l1; Supplemen-
tary Table S1 online and Supplementary
Figure S1 online). More strikingly, we
observed very low specific IgE against
ambrosia in almost 30% of our patients,
with a positive history of allergic reac-
tions to ragweed and a positive SPT to
ambrosia (Supplementary Table S1 on-
line and Supplementary Figure S2 on-
line). These data are very similar to
recently published results showing 8 of
33 patients (24%) with very low specific
IgE radioallergosorbent test (RAST) value
for ragweed but positive history and SPT
(Stokes et al., 2005).
These findings imply that allergic
and/or non-allergic components of
pollen can enhance or even induce
allergy-like symptoms even in the
absence of specific IgE, e.g., by directly
activating MCs in the skin or mucosa
(Mattila et al., 2010). Indeed, extracts of
birch pollen have previously been
shown to directly activate neutrophils,
eosinophils, and dendritic cells (Traidl-
Hoffmann et al., 2002, 2005; Plotz
et al., 2004), and ragweed pollen
extracts can reportedly induce IgE-
independent histamine release from rat
basophilic leukemia cells (Chodaczek
et al., 2009). To assess the potential of
pollen-derived substances to induce
IgE-independent allergy-like inflamma-
tion, we prepared aqueous pollen ext-
racts (APEs) from birch pollen (from
Betula alba sp.), as previously described
(Gilles et al., 2009), and injected the
APE of birch pollen (Bet.-APE) or
vehicle intradermally into the ears of
naı¨ve C57BL/6 mice. After injection,
ear swelling was measured as a para-
meter of skin inflammation at various
timepoints. Injection of Bet.-APE re-
sulted in a rapid and pronounced
inflammatory skin reaction (Figure 1a),
closely mimicking an IgE and antigen-
mediated allergic skin inflammation
(Metz et al., 2006). Furthermore, quan-
titative histomorphometry (Metz et al.,
2009) in alkaline Giemsa-stained plas-
tic-embedded 1-mm sections of the ears
6 hours after injection revealed that
Bet.-APE ear swelling is associated with
an increased percentage of extensively
degranulated MCs (Figure 1b and c).
To further characterize the
mechanisms of Bet.-APE-induced skin
inflammation, we injected various
concentrations of Bet.-APE into the ears
of MC-deficient KitW/KitWv mice and
their respective wild-type Kitþ /þ lit-
termates. Whereas Bet.-APE injection
resulted in strong and dose-dependent
ear swelling in Kitþ /þ mice, virtually
no signs of inflammation were observed
in the ears of MC-deficient mice
(Figure 2a and b). Similar results were
obtained for APE derived from Ambro-
sia artemisiifolia pollen (Supplemen-
tary Figure S3 online). In addition to
their profound deficiency in MCs, KitW/
KitWv mice also lack melanocytes and
interstitial cells of Cajal, and display
some other abnormalities such as slight
anemia (Metz et al., 2007). Therefore,
we selectively repaired the MC defi-
ciency of the ear skin of some KitW/
KitWv mice by engraftment with
bone marrow-derived cultured MCs,
as described previously (Metz et al.,
2006), and injected Bet.-APE into the
ears of MC-engrafted KitW/KitWv mice
(KitW/KitWvþ bone marrow-derived
cultured MCs), normal MC-deficient
mice (KitW/KitWv), and wild-type con-
trols (Kitþ /þ ). As shown in Figure 2c,
the inflammatory skin reaction in res-
ponse to injection of APE was fully
restored in KitW/KitWv mice after the
engraftment with MC (Figure 2c), for-
mally proving that MCs are indeed
responsible for Bet-APE-induced skin
inflammation.
To characterize the nature of the
MC-activating agent within the extracts
of birch and ambrosia pollen, we
prepared different fractions of the APEs
of birch and ambrosia pollen. To obtain
allergen-free APE fractions, the total
extracts were ultra-filtered using 3 kDa
cutoff filters (Amicon ultra YM3, Milli-
pore, Schwalbach, Germany). Interest-
ingly, depending on the type of pollen,
different substances seem to be respon-
sible for the inflammatory response: in
the case of Bet.-APE, the effect was
mediated by a fraction enriched for
compounds o3 kDa (Gilles et al.,
2010) (Figure 2d). In contrast, APE from
ambrosia exhibited inflammatory pot-
ential mainly in the fraction with mole-
cules larger than 3 kDa (Supplementary
Figure S4 online). Future investigations
will have to identify the exact nature of
the MC-activating substances within the
respective pollen extracts.
Taken together, our data show that
water-soluble mediators from birch and
ambrosia pollen can induce MC-depen-
dent but IgE-independent allergy-like
inflammation in murine skin. Using this
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Figure 1. IgE-independent skin inflammation by aqueous pollen extracts from birch (Bet.-APEs) is associated with increased mast cell (MC) degranulation.
Bet.-APE or vehicle (100 mg each) was injected intradermally (in 20ml Dulbecco’s phosphate-buffered saline) into the ears of C57BL/6 mice. MC degranulation
was assessed by quantitative histomorphometry in alkaline Giemsa-stained sections. Data are derived from three independent experiments,
(a) nX11 per group, (b) n¼ 4; ***Po0.005, *Po0.01. Images in c are representative of not degranulated, moderately degranulated, and extensively
degranulated MCs; original magnification  100, bar¼ 20mm.
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model, we provide a proof of concept
for pollen-associated but allergen-
independent inflammation. It has to be
noted, however, that one has to be
careful in extrapolating from the murine
model system to the patients. For exam-
ple, in ‘‘real life’’, pollen components
will rarely be injected intradermally.
Nevertheless, in some tissues such as
the upper airway epithelium, pollen-
derived substances could penetrate and
get in direct contact with MCs. In the
skin of patients with inflamed skin, e.g.,
patients with atopic dermatitis, barrier
defects provide greater access for toxins,
microbes, and allergens (Hanifin, 2009).
This could also facilitate direct con-
tact of pollen components with MCs.
Furthermore, although human MCs also
express a huge amount of potent inflam-
matory mediators and share many of the
same mechanisms of activation, there
are certain functional differences bet-
ween murine and human MCs (Bischoff,
2007; Metz et al., 2008).
The inflammatory effects of pollen
components observed in mouse skin
may account for the seasonal allergy-
like clinical symptoms experienced by
some patients. In the patients reported
here, we considered specific IgE levels
o0.7 kU l1 (CAP class 0 and 1) to be
of limited clinical relevance. However,
especially in those patients with low
levels of specific IgE, non-allergic sub-
stances from pollen may enhance the
reactivity of MCs and thus promote
aggravation of allergic diseases. No
detectable levels of specific IgE
(o0.1 kU l1) against birch or ambrosia
were found in 3.6 and 5.3% of the
symptomatic patients with positive SPT,
respectively (Supplementary Figures S1
and S2 online). In these patients, a
direct effect of non-allergic pollen
mediators on MCs similar to the ob-
served effects in mice seems possible.
Susceptibility for this non-allergic
pollen-associated inflammation may
depend on the status of the epithelial
barrier or differences in the sensitivity
of MCs between individuals (i.e., be-
cause of genetic differences, differences
in the microenvironment, or simulta-
neous minimal activation by specific
IgE and the respective allergen in
those patients with low levels of spe-
cific IgE).
Another interesting speculation is
that these mediators could also serve
as adjuvants in sensitization to aller-
gens. McLachlan et al. (2008) recently
demonstrated that antigen-specific ser-
um IgG responses to a vaccine antigen
can be largely increased by co-admin-
istration of a MC activator. Our data
presented here indicate that pollen can
provide both MC activation and aller-
gen challenge at the same time,
and it will be of great interest to
investigate whether this may also lead
to enhanced production of IgE and thus
increased sensitization to the respective
allergen.
All animal care and experimentation
were conducted at Charite´-Universita¨ts-
medizin Berlin in accordance with
current federal, state, and institutional
guidelines.
In all investigations involving pat-
ients, the patients’ written, infor-
med consent was obtained and the
Declaration of Helsinki protocols were
followed.
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Figure 2. Aqueous pollen extracts from birch (Bet.-APEs) induce mast cell (MC)-dependent skin inflammation in mice. Ears of naı¨ve wild-type Kitþ /þ
mice (a, c), MC-deficient KitW/KitWv mice (b, c), KitW/KitWv mice that have been locally and selectively engrafted with MCs (KitW/KitWvþ bone
marrow-derived cultured mast cell (BMCMC), (c)) or C57BL/6 mice were injected intradermally with 100 mg Bet.-APE or as indicated (in 20 ml Dulbecco’s
phosphate-buffered saline). (a, b) nX6 mice/group, (c) nX12 , (d) n¼ 4; ***Po0.005.
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TO THE EDITOR
Calcipotriol is used as a first-line topical
agent in the treatment of psoriasis.
Inhibition of keratinocyte proliferation,
repression of growth signals, and
modulation of T-cell signaling have
been proposed to contribute to the
clinical effects of calcipotriol (Scott
et al., 2001). However, the precise
mechanism of action of calcipotriol
and related vitamin D analogs remains
poorly understood. Recent studies have
implicated vitamin D in autophagy
induction in a variety of cell types
including MCF-7 breast carcinoma cells
(Hoyer-Hansen et al., 2007), human
myeloid leukemia cells (Wang et al.,
2008), and human monocytes (Yuk
et al., 2009). During autophagy, intra-
cellular contents are enveloped in
double-layered membrane vesicles that
fuse with lysosomes for degradation
(Mizushima et al., 2010). This ‘‘recy-
cling’’ process is highly regulated and
may be activated by a variety of stimuli
including infections, starvation, mis-
folded proteins, and mitochondrial
stress. In this study we find that
calcipotriol, a commonly prescribed
topical analog of vitamin D, also
induces autophagy in both HeLa cells
and keratinocytes.
The induction of autophagy is char-
acterized by specific histological and
biochemical changes (Mizushima et al.,
2010). Under basal conditions, micro-
tubule-associated protein 1 light chain
3 beta (LC3) is a diffuse cytosolic
protein. After autophagy induction,
LC3 is proteolytically cleaved, lipi-
dated, and localizes to autophagosomal
membranes, forming punctate subcel-
lular structures. Using a HeLa cell line
that expresses a green fluorescent
protein-LC3 (GFP-LC3) fusion protein
(Orvedahl et al., 2010), we assessed
whether calcipotriol alters the subcel-
lular distribution of LC3. Indeed, calci-
potriol treatment (40 nM for 24 hours)
caused a striking induction of GFP-LC3Abbreviations: NHK, normal human keratinocyte; VDR, vitamin D receptor
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